AbbVie stock forecast 2025 factors in macroeconomic variables such as interest rate stabilization and healthcare policy shifts. Equity strategists see ABBV benefiting from defensive positioning in volatile markets due to consistent dividend payouts. The White House has warned that if the government shutdown lingered, it would trigger widespread dismissals of employees in government programs that don’t align with President Trump’s priorities. Bloomberg Economics estimates that 640,000 federal workers will be furloughed during a shutdown, which would expand jobless claims and push the unemployment rate up to 4.7%. Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data. The AbbVie stock forecast 2025 from sector specialists incorporates expectations of regulatory approvals for novel migraine and oncology treatments. This could help sustain revenue momentum above $65 billion annually, maintaining ABBV’s large-cap growth profile.